Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | PPARG | P37231 | 8/20 | 0.43 |
| ▸ | PPARA | Q07869 | 6/20 | 0.43 |
| ▸ | MAOB | P27338 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | S1PR1 | P21453 | 3/20 | 0.39 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.39 |
| ▸ | CTSB | P07858 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18243 | 1.00 | NPC1 (0.49) | NPC1RAB9APPARGPPARAMAOB | |
| SCHEMBL26318 | 0.93 | NPC1 (0.53) | NPC1RAB9APPARGPPARAMAOB | |
| SCHEMBL26317 | 0.93 | NPC1 (0.53) | NPC1RAB9APPARGPPARAMAOB | |
| SCHEMBL4667807 | 0.88 | NPC1 (0.48) | NPC1RAB9APPARGPPARAMAOB | |
| SCHEMBL4563137 | 0.87 | PPARG (0.39) | NPC1RAB9APPARGMAOBMEN1 | |
| SCHEMBL31532164 | 0.85 | NPC1 (0.51) | NPC1RAB9APPARGPPARAMAOB | |
| SCHEMBL4624388 | 0.83 | S1PR1 (0.50) | NPC1RAB9APPARGPPARAMEN1 | |
| SCHEMBL4624392 | 0.83 | S1PR1 (0.50) | NPC1RAB9APPARGPPARAMEN1 | |
| SCHEMBL29060560 | 0.83 | LMNA (0.39) | NPC1RAB9APPARGMEN1KMT2A | |
| SCHEMBL25344075 | 0.82 | NPC1 (0.50) | NPC1RAB9APPARGPPARAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100292237-A1 | Method for Combating Phytopathogenic Fungi | BASF SE (DE) | 2010-11-18 | — | — | US | claimed |
| US-20090233916-A1 | METHOD OF INDUCING VIRUS TOLERANCE OF PLANTS | BASF SE (DE) | 2009-09-17 | — | — | US | claimed |
| US-20090011935-A1 | Method of Inducing Tolerance of Plants Against Bacterioses | BASF SE (DE) | 2009-01-08 | — | — | US | claimed |
| EP-2001294-A2 | METHOD FOR COMBATING PHYTOPATHOGENIC FUNGI | BASF SE (DE) | 2008-12-17 | — | — | EP | claimed |
| EP-1996018-A2 | METHOD OF INDUCING TOLERANCE OF PLANTS AGAINST BACTERIOSES | BASF SE (DE) | 2008-12-03 | — | — | EP | claimed |
| EP-1993358-A2 | METHOD OF INDUCING VIRUS TOLERANCE OF PLANTS | BASF SE (DE) | 2008-11-26 | — | — | EP | claimed |
| WO-2007110354-A2 | METHOD FOR COMBATING PHYTOPATHOGENIC FUNGI | BASF SE (DE) | 2007-10-04 | — | — | WO | claimed |
| WO-2007104669-A2 | METHOD OF INDUCING VIRUS TOLERANCE OF PLANTS | BASF SE (DE) | 2007-09-20 | — | — | WO | claimed |
| WO-2007104658-A2 | METHOD OF INDUCING TOLERANCE OF PLANTS AGAINST BACTERIOSES | BASF SE (DE) | 2007-09-20 | — | — | WO | claimed |
| US-20170359965-A1 | POLYLACTIC ACID COMPOSITIONS WITH ACCELERATED DEGRADATION RATE AND INCREASED HEAT STABILITY | DU PONT (US) | 2017-12-21 | — | — | US | disclosed |
| WO-2016099916-A1 | POLYLACTIC ACID COMPOSITIONS WITH ACCELERATED DEGRADATION RATE AND INCREASED HEAT STABILITY | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2016-06-23 | — | — | WO | disclosed |
| US-20160095321-A1 | SANDPAPER MUTANTS OF BACILLUS AND METHODS OF THEIR USE TO ENHANCE PLANT GROWTH, PROMOTE PLANT HEALTH AND CONTROL DISEASES AND PESTS | AGRAQUEST, INC. | 2016-04-07 | — | — | US | disclosed |
| US-9049814-B2 | Coated seeds and methods of making coated seeds | VAMTECH, LLC (US) | 2015-06-09 | — | — | US | disclosed |
| US-20130180173-A1 | PLANT ARTIFICIAL SEEDS HAVING MULTILAYERS AND METHODS FOR THE PRODUCTION THEREOF | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-07-18 | — | — | US | disclosed |
| WO-2006108834-A1 | USE OF BASIC AMINO ACIDS IN BIOCIDE FORMULATIONS CONTAINING COPPER | BASF AKTIENGESELLSCHAFT (DE) | 2006-10-19 | — | — | WO | disclosed |
| WO-2006108835-A2 | USE OF POLYLYSINE IN BIOCIDE FORMULATIONS CONTAINING COPPER | BASF AKTIENGESELLSCHAFT (DE) | 2006-10-19 | — | — | WO | disclosed |
| WO-2006000383-A1 | AQUEOUS DISPERSIONS COMPRISING ACTIVE SUBSTANCES THAT ARE DIFFICULT OR IMPOSSIBLE TO DISSOLVE IN WATER, AND DRY POWDERS WHICH ARE PRODUCED THEREFROM AND CONTAIN AT LEAST ONE POLYMER CONTAINING POLYETHER GROUPS AS A PROTECTIVE COLLOID | BASF AKTIENGESELLSCHAFT (DE) | 2006-01-05 | — | — | WO | disclosed |
| WO-2006000592-A1 | USE OF ETHER GROUP-CONTAINING POLYMERS AS SOLUBILIZERS | BASF AKTIENGESELLSCHAFT (DE) | 2006-01-05 | — | — | WO | disclosed |
| WO-2005077170-A1 | FORMULATION FOR SEED TREATMENT COMPRISING POLYMERIC STICKERS | BASF AKTIENGESELLSCHAFT (DE) | 2005-08-25 | — | — | WO | disclosed |
| WO-2005077169-A1 | FORMULATION FOR SEED TREATMENT | BASF AKTIENGESELLSCHAFT (DE) | 2005-08-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090011935-A1 | Method of Inducing Tolerance of Plants Against Bacterioses | BROX, CAT, SLC11A2 | NPC1 1971/4885RAB9A 3551/4885PPARG 426/4885 |
| US-20100292237-A1 | Method for Combating Phytopathogenic Fungi | CYC1, UQCRC1, MT-CO2 | NPC1 884/4885RAB9A 3649/4885PPARG 3409/4885 |
| US-20090233916-A1 | METHOD OF INDUCING VIRUS TOLERANCE OF PLANTS | EIF2AK2, CAT, SLC11A2 | NPC1 2103/4885RAB9A 3589/4885PPARG 1025/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.